Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.
about
Can Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized IndividualsIncidence and clinical impact of stent fracture after the Nobori biolimus-eluting stent implantation.Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study.Experience with BioMatrix BES and other DES in all-comers setting: a retrospective overview.The Nobori biolimus-eluting stent: update of available evidence.From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.Safety and efficacy outcomes of 3rd generation DES in an all-comer population of patients undergoing PCI: 12-month and 24-month results of the e-Biomatrix French registry.Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCEL2) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort StudyLong-Term Clinical Outcomes of a Biodegradable Polymer-Based Biolimus-Eluting Stent.Outcomes following implantation of the Biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry.Differences of side branch jailing between left main-left anterior descending artery stenting and left main-left circumflex artery stenting with Nobori biolimus-eluting stent.Procedural and follow-up outcomes among patients undergoing successful recanalisation of coronary chronic total occlusions using biolimus drug-eluting stents.Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.
P2860
Q28551120-845BA36B-CDCF-4CA3-BD9B-0BEF44B86549Q34297112-BC32B9C7-5E6C-4579-B7FF-159470215CFFQ35097440-CC636B37-94F0-436B-990E-158BDCC6EE4CQ37526533-FFDC51C8-48CB-4D79-A747-1678345CED8DQ38192032-46624709-845D-4724-893E-ABDDCF0FB024Q38702003-208913F8-6476-4E11-8AC8-83B037581B1AQ38764070-D6AB8916-8A77-4F50-B3D9-D67E0882FF4BQ38969182-396555E6-875D-429C-BD4B-94BD6B849F3CQ39005826-31353DE6-D81A-42B2-BAE2-D5CA66A6FCCAQ39053571-30455C9B-1CD7-40F5-BB59-0520926BCEE1Q39502082-2735D6A4-C2F3-4D31-9AA8-1BB55C649D21Q39811154-6AC28698-9D03-47B6-9A73-485585C3848BQ39959015-17713526-0DDD-451E-A1C5-F8BB00BDDB99Q40257227-D35D8E5C-59DF-4493-AC4A-A81A3096E543Q53176367-6CBAB450-E6F6-4D46-B690-4D8DCFA0700FQ53634713-2DA25091-7251-4940-AFBA-10560475D531Q54960240-0FC12E05-B7DD-4F76-962B-184E4F3C0317
P2860
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical performance of a drug ...... opulation: the NOBORI 2 study.
@en
type
label
Clinical performance of a drug ...... opulation: the NOBORI 2 study.
@en
prefLabel
Clinical performance of a drug ...... opulation: the NOBORI 2 study.
@en
P2093
P50
P356
P1476
Clinical performance of a drug ...... population: the NOBORI 2 study
@en
P2093
Amerigo Stabile
Antonio Serra
Bernard Chevalier
Dragan Sagic
Dragica Paunovic
Farzin Fath-Ordoubadi
Gerhard Strupp
Javier Goicolea Ruigomez
Marcus Wiemer
NOBORI 2 Investigators
P304
P356
10.4244/EIJV8I1A17
P577
2012-05-01T00:00:00Z